United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 12, 2026 · Filed Aug 13, 2026

On Aug 12, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$515.03 for US$4.89M under a trading plan, leaving 324,443 shares. Filed Aug 13, 2026 (Form 4).

Sold
9,500 shares
Price
US$515.03 average (US$507.08 to US$520.96)
Value
US$4.89M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 12, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 12, 2026Common StockSale40US$507.08333,903Indirect
Aug 12, 2026Common StockSale440US$508.86333,463Indirect
Aug 12, 2026Common StockSale280US$509.61333,183Indirect
Aug 12, 2026Common StockSale1,152US$511.12332,031Indirect
Aug 12, 2026Common StockSale542US$511.75331,489Indirect
Aug 12, 2026Common StockSale1,206US$513.02330,283Indirect
Aug 12, 2026Common StockSale558US$514.18329,725Indirect
Aug 12, 2026Common StockSale893US$514.87328,832Indirect
Aug 12, 2026Common StockSale940US$516.16327,892Indirect
Aug 12, 2026Common StockSale1,249US$517.21326,643Indirect
Aug 12, 2026Common StockSale320US$518.16326,323Indirect
Aug 12, 2026Common StockSale1,160US$519.49325,163Indirect
Aug 12, 2026Common StockSale679US$520.38324,484Indirect
Aug 12, 2026Common StockSale41US$520.96324,443Indirect

Source

View original at SEC

Related